NDC 0409-4684-17 - Fluconazole in Dextrose
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-4684
- Requested NDC
- 0409-4684-17
- Package NDCs from labels
- 0409-4684-16, 0409-4684-12, 0409-4684-17, 0409-4684-13
- Manufacturer
- Hospira, Inc.
- Effective date
- 2019-03-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fluconazole in Dextrose Injection, USP | Hospira, Inc. | 2019-03-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-4684-02 | ML - Milliliter | 0409-4684 | 01518434-3e5a-4938-a005-9357b909df75 | 1 | 2012-07-24 |
| 0409-4684-06 | ML - Milliliter | 0409-4684 | ee38e425-01bf-48a5-8593-e82afbe88344 | 1 | 2015-04-03 |
| 0409-4684-12 | ML - Milliliter | 0409-4684 | 4e2f3798-2b65-4963-8687-5802aaec77f0 | 1 | 2016-01-13 |
| 0409-4684-13 | ML - Milliliter | 0409-4684 | 26653e4e-3a1f-48c2-9fa2-767a20e2fcf0 | 1 | 2016-12-07 |
| 0409-4684-16 | ML - Milliliter | 0409-4684 | e892b8e7-61ac-4ad2-add6-d4c24fbe6403 | 1 | 2016-12-07 |
| 0409-4684-17 | ML - Milliliter | 0409-4684 | 9a76f155-7a59-4d12-aedf-2708a5304b40 | 1 | 2016-12-07 |
| 0409-4684-23 | ML - Milliliter | 0409-4684 | d49e5063-4c58-494d-bd89-bd02d81fd9c3 | 1 | 2012-07-24 |
| 0409-4684-27 | ML - Milliliter | 0409-4684 | 6d229e02-b212-4c13-9f0d-e12957df4a0e | 1 | 2015-04-03 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | c1f72bce-4bef-49db-a8da-f26a703d6748 | 2024-08-15 | Warnings, Adverse reactions | LX22YL083G |
| Fluconazole | FLUCONAZOLE | Aurobindo Pharma Limited | bf588f7e-89de-4b4e-8d33-c1ff2be1b34e | 2024-08-09 | Warnings, Adverse reactions | 8VZV102JFY |
| Fluconazole | FLUCONAZOLE | NorthStar Rx LLC | d2acccda-8068-46c1-8562-950d7f70ee06 | 2024-07-04 | Warnings, Adverse reactions | 8VZV102JFY |
| Fluconazole | FLUCONAZOLE | Rising Pharma Holdings, Inc. | 2ca7efcd-4a8d-4139-a3eb-930afd18b13f | 2024-07-04 | Warnings, Adverse reactions | 8VZV102JFY |
| Fluconazole | FLUCONAZOLE | Hikma Pharmaceuticals USA Inc. | d3ca59bd-ae00-48ab-89aa-87c7f56e9989 | 2024-06-28 | Warnings, Adverse reactions | 8VZV102JFY |
| Fluconazole | FLUCONAZOLE | Baxter Healthcare Company | cd24a261-9c15-42b4-8040-89d2dbda174e | 2024-06-24 | Warnings, Adverse reactions | 8VZV102JFY |
| Isolyte P in Dextrose | DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC | B. Braun Medical Inc. | 4ea4397c-2fa4-4670-91e6-21ae498c88f7 | 2024-06-24 | Warnings, Adverse reactions | LX22YL083G |
| fluconazole | FLUCONAZOLE | NuCare Pharmaceuticals,Inc. | 715c53f0-2aea-1f24-e053-2995a90ad463 | 2024-06-10 | Warnings, Adverse reactions | 8VZV102JFY |
| Fluconazole | FLUCONAZOLE | Pharmasource Meds, LLC | fe0cc56d-c0b6-f859-e053-6294a90ad932 | 2024-05-28 | Warnings, Adverse reactions | 8VZV102JFY |
| Potassium Chloride in Lactated Ringers and Dextrose | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, AND DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | dbed53b7-0109-4561-8342-0178ec8c64b0 | 2024-05-22 | Warnings, Adverse reactions | LX22YL083G |
| Lactated Ringers and Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 1b912c7e-f005-4af4-b683-083440964249 | 2024-05-22 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | 55d9ae37-4553-47e7-a2e3-86b48b5227cd | 2024-05-08 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | f0cc6713-4d47-49be-8116-901c99002b6b | 2024-05-07 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | 97001218-086c-430a-9e0d-6c7031c91d94 | 2024-05-06 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | Fresenius Kabi USA, LLC | fe5b5182-c859-4c74-b2e0-467be5b2e329 | 2024-05-06 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Fresenius Kabi USA, LLC | f2379398-a07b-417e-a022-f7b41f962067 | 2024-04-24 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose monohydrate | DEXTROSE MONOHYDRATE | HF Acquisition Co LLC, DBA HealthFirst | d7c4f9eb-9b89-c5a3-e053-2a95a90a28a2 | 2024-02-22 | Warnings, Adverse reactions | LX22YL083G |
| 50% DEXTROSE | 50% DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | 763b1cb8-1151-5f59-e053-2991aa0a4e01 | 2024-02-22 | Warnings, Adverse reactions | LX22YL083G |
| DEXTROSE | DEXTROSE | HF Acquisition Co LLC, DBA HealthFirst | 75c902e8-50e7-a337-e053-2991aa0a2093 | 2024-02-19 | Warnings, Adverse reactions | LX22YL083G |
| Fluconazole | FLUCONAZOLE | Direct Rx | 69f199fa-bb92-4837-8b12-427a1c71f622 | 2024-01-09 | Adverse reactions | 8VZV102JFY |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.